Published in Breast Cancer Weekly, March 4th, 2000
A "who's who" of breast cancer experts from medical institutions around the world have agreed upon a series of treatment options for Ductal Carcinoma In Situ (DCIS), a controversial malignancy found in the breast, as an important new step toward improving patient treatment for this type of early breast cancer. DCIS currently represents 25 to 30% of all breast cancers diagnosed.
In a paper to be published concurrently by three medical journals - Cancer, Human Pathology, and The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Breast Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.